Drug intelligence / Profile preview

PsiThera-sTNFα

Development stage
Preclinical
Lead developer
PsiThera
Modality
Small Molecules
Administration
Oral
01

Overview

PsiThera-sTNFα is an oral small-molecule inhibitor of soluble tumor necrosis factor alpha (sTNFα) currently in the discovery stage of development by PsiThera. Designed as an "Antibody-in-a-Pill," the therapeutic aims to provide the potent, high-affinity blockade of TNFα typically associated with injectable monoclonal antibodies but in a more convenient oral format. The program utilizes a proprietary platform that combines physics-based modeling, artificial intelligence, and structural biology to target complex cytokine systems where biologics have traditionally dominated. It is being developed for the treatment of autoimmune and inflammatory conditions, specifically within the fields of rheumatology and inflammatory bowel disease (IBD).

Other names
soluble TNF alphasTNFα (soluble TNFα)PsiThera-sTNFα (soluble TNF alpha)-small molecule-oral-Rheumatology-Inflammatory Bowel Disease
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on PsiThera-sTNFα.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PsiThera-sTNFα.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call